Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.
By D. V. Von Hoff, J. Stephenson, P. Rosen, D. Loesch, M. Borad, S. Anthony, G. Jameson, Susan Brown, Nina Cantafio, D. Richards and 9 more. Journal of Clinical Oncology, 2010
612 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/c84343fba8b57c867c06eb830262a7060d85af90
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Molecular Biology
Citations in the corpus
- Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA (2015, background): “3-fold or longer compared to their previous line of therapy in 27% (95% CI, 17% to 38%) of tested patients [64].”